INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 211 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,979,000 | -64.9% | 56,915 | -75.0% | 0.17% | -65.3% |
| Q3 2021 | $8,478,000 | -33.7% | 227,419 | -27.4% | 0.50% | -31.9% |
| Q2 2021 | $12,783,000 | -42.5% | 313,159 | -52.2% | 0.74% | -44.8% |
| Q1 2021 | $22,224,000 | -17.6% | 655,001 | -22.8% | 1.34% | -16.8% |
| Q4 2020 | $26,972,000 | +108.7% | 848,162 | +68.4% | 1.61% | +67.6% |
| Q3 2020 | $12,921,000 | +108.1% | 503,555 | +108.2% | 0.96% | +145.0% |
| Q2 2020 | $6,209,000 | +676.1% | 241,908 | +365.2% | 0.39% | +428.4% |
| Q1 2020 | $800,000 | -51.1% | 52,005 | -58.7% | 0.07% | -50.7% |
| Q2 2019 | $1,635,000 | – | 125,955 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |